VIDO has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the United States’ National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
On August 24th, VIDO hosted a half-day summit on foot-and-mouth disease (FMD). Our biannual Animal Health Summit will bring together stakeholders to facilitate knowledge exchange and preparedness on a topic of interest.
VIDO has signed a memorandum of understanding (MOU) with the Centre for Veterinary Vaccine Innovation and Manufacturing at the Pirbright Institute in the UK. The MOU allows for expanded animal health collaborations and training.